2013年进入日本九州大学工学府上平正道实验室，2017年获博士学位。毕业后回国进入上海交通大学医学院从事博士后工作，在此期间，获国自然青年科学基金项目1项、中国博士后面上基金1项。2020年被复旦大学发育生物学研究所聘为青年副研究员，从事肿瘤类器官方向研究。

课题研究方向为肿瘤类器官和微环境的研究，主要包括：1.中胚层及内胚层肿瘤类器官的建立；2，类器官模拟肿瘤免疫微环境的研究；3，乏氧微环境调控肿瘤代谢及耐药逆转。

2016年 日本化工会 优秀论文奖

2018年 上海市超级博士后

2019年 日本癌症大会  CHAAO Travel Grant

1.Jing Chen#, Xue Wang#, Yuan Yuan#, Haoting Chen, Lingpu Zhang, Haihua Xiao, Jingqi Chen, Yongxiang Zhao, Jin Chang,* Weisheng Guo,* Xing-Jie Liang*. Exploiting the Acquired Vulnerability of Cisplatin-Resistant Tumor with a Hypoxia-Amplifying DNA Repair-Inhibiting (HYDRI) Nanomedicine. Science advances, 2021, in press.

2.Xue Wang#, Hong Zhu#, Lei Lei#, Yang Zhang, Chao Tang, Jia-xing Wu, Jie-ru Zhou,* Xi-rong Xiao*. Integrated Analysis of Key Genes and Pathways Involved in Fetal Growth Restriction and Their Associations With the Dysregulation of the Maternal Immune System. Frontiers in genetics, 2021, in press.

3.Huizhen Sun#, Husheng Wang#, Xue Wang#, Yoichi Aoki, Xinjing Wang, Yufei Yang, Xi Cheng, Ziliang Wang,* Xipeng Wang*. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells. Theranostics, 2020, 10(15):6928-6945.

4.Xue Wang, Fei-kai Lin, Jia-rui Li,* Hu-sheng Wang*. A comprehensive risk assessment model for ovarian cancer patients with phosphor-STAT3 and IL-31 as immune infiltration relevant genes. OncoTarget and therapy, 2020, 13:5617-5628.

5.Xue Wang, Yoshinori Kawabe, Takeshi Hada, Akira Ito, Masamichi Kamihira*. Cre-Mediated Transgene Integration in Chinese Hamster Ovary Cells Using Minicircle DNA Vectors. Biotechnology journal, 2018, 13(7):e1800063.